收藏切换
Construction of protection system for varieties of traditional Chinese medicines oriented by intellectual property rights
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(12) : 4541 - 4548
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(12): 4541-4548
Construction of protection system for varieties of traditional Chinese medicines oriented by intellectual property rights
Full
LI Hui1,2
Affiliations
    1 College of Marxism, Zhejiang Chinese Medical University, Hangzhou 311402, China;
    2 Institute of Zhejiang Chinese Medical Culture, Zhejiang Chinese Medical University, Hangzhou 310053, China
doi: 10.7501/j.issn.0253-2670.2025.12.034
Outline
收藏切换
Our country has assigned different responsibilities to the protection system for varieties of traditional Chinese medicines (TCM) at different times. To make up for the deficiencies of the patent system, transform from a drug supervision and management system to a sui generis system for TCM, which promotes high-quality innovation and development of TCM varieties, should be its way out. The both focus on inheritance and innovation, clinical value dominance, balance of interests, and taking into account the characteristics of TCM and international practices should be the principles of the construction. In system construction, TCM decoction pieces should be included in the protection scope alongside ready-made TCM (beyond raw materials), and graded protection should be replaced by classified protection to align with international concepts and the classification rules of the Measures for the Administration of Drug Registration (2020). Enterprises should be added as rights holders, the production rights of TCM varieties should be alienable, and “National Protected Variety of TCM” mark right should be added. The protection period should be adjusted to 5—15 years to conform to specific intellectual property protection systems for pharmaceuticals in the international community.
protection of traditional Chinese medicine varieties  /  system construction  /  clinical efficacy  /  innovation encouragement  /  balance of interests  /  the sui generis system
李慧. 以知识产权为导向的中药品种保护制度构建. 中草药, 2025 , 56 (12) : 4541 -4548 . DOI: 10.7501/j.issn.0253-2670.2025.12.034
LI Hui. Construction of protection system for varieties of traditional Chinese medicines oriented by intellectual property rights[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (12) : 4541 -4548 . DOI: 10.7501/j.issn.0253-2670.2025.12.034
Year 2025 volume 56 Issue 12
51
7
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.12.034
  • Receive Date:2025-02-01
  • Online Date:2026-11-13
Article Data
Affiliations
History
  • Received:2025-02-01
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.12.034
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT